GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Dividend Yield %

LakeShore Biopharma Co (LakeShore Biopharma Co) Dividend Yield % : 0.00% (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Dividend Yield %?

As of today (2024-06-05), the Trailing Annual Dividend Yield of LakeShore Biopharma Co is 0.00%.

The historical rank and industry rank for LakeShore Biopharma Co's Dividend Yield % or its related term are showing as below:

LSB's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.58
* Ranked among companies with meaningful Dividend Yield % only.

LakeShore Biopharma Co's Dividend Payout Ratio for the six months ended in Sep. 2023 was 0.00.

As of today (2024-06-05), the Forward Dividend Yield % of LakeShore Biopharma Co is 0.00%.

LakeShore Biopharma Co's Dividends per Share for the six months ended in Sep. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


LakeShore Biopharma Co Dividend Yield % Historical Data

The historical data trend for LakeShore Biopharma Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Dividend Yield % Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Dividend Yield %
- - -

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of LakeShore Biopharma Co's Dividend Yield %

For the Biotechnology subindustry, LakeShore Biopharma Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Dividend Yield % falls into.



LakeShore Biopharma Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


LakeShore Biopharma Co  (NAS:LSB) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


LakeShore Biopharma Co Dividend Yield % Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.